EQIX vs TERN · P/E 79, rev $9.22B vs $6.12B cap
Equinix Inc (EQIX) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
Equinix Inc (EQIX) is a reit - specialty company listed on US.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported EQIX revenue for 2025-12-31 was $9.22B. Net income was $1.35B. Revenue was up 5.4% from 2024-12-31 to 2025-12-31. EQIX currently screens at market cap $74.23B and trailing P/E 79.4.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
EQIX currently screens at market cap $74.23B and trailing P/E 79.4. TERN currently screens at market cap $6.12B.
Not investment advice. Open the EQIX and TERN stock pages for the full models.
Not investment advice.